COVID-19

Parsemus supports study of metformin to fight COVID-19

The Parsemus Foundation has provided seed funding to initiate research on use of the common diabetes medication metformin for prevention and treatment of COVID-19. The clinical study will be carried out by a team at the University of Minnesota led by co-principal investigators Carolyn Bramante, MD, MPH in the Department of Medicine and Christopher Tignanelli,… Read more


Unraveling the link between diabetes and COVID-19

One of the risk factors for severe illness from COVID-19 is diabetes. While scientists aren’t sure why diabetes leads to poorer outcomes for COVID-19 patients, early studies indicate that controlling blood sugar may be an important component of treatment. Researchers from across the globe have been reporting that patients who have blood glucose monitoring and… Read more